|
注册号: Registration number: |
ChiCTR2000038063 |
|
最近更新日期: Date of Last Refreshed on: |
2020-11-22 15:21:35 |
|
注册时间: Date of Registration: |
2020-09-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
董静医师:请与我们联系上传伦理审批文件;请补充随机方法内容的填写。 基于学校的人群减盐干预项目 |
|
Public title: |
School-based population salt reduction intervention program |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
基于学校的人群减盐干预项目 |
|
Scientific title: |
School-based population salt reduction intervention program |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
董静 |
研究负责人: |
郭晓雷 |
|
Applicant: |
Dong Jing |
Study leader: |
Guo xiaolei |
|
申请注册联系人电话: Applicant telephone: |
+86 18615281798 |
研究负责人电话:
Study leader's |
+86 18615281799 |
|
申请注册联系人传真 : Applicant Fax: |
+86 531-82679489 |
研究负责人传真: Study leader's fax: |
+86 531-82679690 |
|
申请注册联系人电子邮件: Applicant E-mail: |
freedom.dj1@163.com |
研究负责人电子邮件: Study leader's E-mail: |
guoxiaolei@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
济南市经十路16992号 |
研究负责人通讯地址: |
济南市经十路16992号 |
|
Applicant address: |
16992 Jingshi Road, Jinan, China |
Study leader's address: |
16992 Jingshi Road, Jinan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
250014 |
研究负责人邮政编码: Study leader's postcode: |
250014 |
|
申请人所在单位: |
山东省疾病预防控制中心 |
||
|
Applicant's institution: |
Shandong Center for Disease Control and Prevention |
||
|
研究负责人所在单位: |
山东省疾病预防控制中心 |
||
|
Affiliation of the Leader: |
Shandong Center for Disease Control and Prevention |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
伦研批第(2020-7)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
|
|
批准本研究的伦理委员会名称: |
山东省疾病预防控制中心预防医学伦理委员会 |
||
|
Name of the ethic committee: |
Preventive Medicine Ethics Committee of Shandong Center for Disease Control and Prevention |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-05-22 00:00:00 | ||
|
伦理委员会联系人: |
丁淑军 |
||
|
Contact Name of the ethic committee: |
Ding shujun |
||
|
伦理委员会联系地址: |
济南市经十路16992号 |
||
|
Contact Address of the ethic committee: |
16992 Jingshi Road, Jinan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
山东省疾病预防控制中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Shandong Center for Disease Control and Prevention |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
济南市经十路16992号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
16992 Jingshi Road, Jinan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
卫健策略 |
||||||||||||||||||||||
|
Source(s) of funding: |
Vital Strategies |
||||||||||||||||||||||
|
研究疾病: |
减盐防控高血压 |
||||||||||||||||||||||
|
Target disease: |
Reducing salt to prevent hypertension |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(一)制定学校减盐干预工作计划,提高学生和教师减盐控压的知信行水平。 (二)通过“小手拉大手”活动,以学生为纽带,将减盐干预活动辐射到整个家庭,提高学生家长(尤其是家中做饭的人员)减盐控压的知信行水平,促进和改善家庭中高血压患者的血压控制,减少新发高血压。 (三)探索、完善以学校为基础的有效、可行、可持续和可负担的减盐干预方案,并在更多的地区获得推广。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) Formulate the school salt reduction intervention work plan to improve the knowledge, trust and practice level of students and teachers in salt reduction and pressure control. (2) Through the "little hand and big Hand" activity, the salt reduction intervention activities are extended to the whole family with students as the bond, so as to improve the knowledge, trust and practice level of students' parents (especially those who cook at home) in salt reduction and pressure control, promote and improve the blood pressure control of hypertension patients in the family, and reduce newly developed hypertension. (3) To explore and improve effective, feasible, sustainable and affordable school-based salt reduction interventions and promote them in more areas. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
本项目分为三个阶段逐步推进。第一阶段为随机对照试验阶段,目的是测试和评价为本项目针对性开发的小学生及其家庭减盐行为干预技术的适用性和干预效果。第二阶段为试点区扩大推广阶段。目的是再第一阶段取得经验的基础上,在试点区内进一步推广上述干预技术,了解大范围推广上述干预技术的可行性和效果。第三阶段为全试点区扩大推广阶段。目的是在总结前两个阶段工作的基础上,进一步将小学生及其家庭减盐行为干预技术推广到覆盖全试点区范围,促进三减三健行动取得实效。 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
The project will be phased into three stages.The first phase is a randomized controlled trial, which aims to test and evaluate the applicability and effect of the salt reduction behavior intervention technology for primary school students and their families specifically developed for this project.The second stage is the expansion and promotion of the pilot area.The purpose is to further popularize the above intervention technologies in the pilot areas on the basis of the experience gained in the first stage, so as to understand the feasibility and effect of large-scale popularization of the above intervention technologies.The third stage is the expansion and promotion of the whole trial area.The purpose is to further extend the salt reduction behavior intervention technology of primary school students and their families to cover the whole pilot area on the basis of summarizing the work of the first two stages, so as to promote the effectiveness of the three reduction and three health care action. |
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
无 |
||||||||||||||||||||||
|
Exclusion criteria: |
Nil |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-09-11 00:00:00至 To 2021-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-09-11 00:00:00 至 To 2021-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
整群随机分组 请说明何人使用何种方法产生随机序列? |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
cluster randomization |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
董静 freedom.dj1@163.com |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Dong Jing freedom.dj1@163.com |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
无/No |